An evaluation of ibrexafungerp for the treatment of invasive candidiasis: the evidence to date-Reference-Cited by-同舟云学术

An evaluation of ibrexafungerp for the treatment of invasive candidiasis: the evidence to date

Published:2021-02-27 Issue:7 Volume:22 Page:797-807
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Colombo Rhonda E¹,Vazquez Jose A²

Affiliation:

1. Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA

2. Division of Infectious Disease, Department of Medicine, Medical College of Georgia/Augusta University, Augusta, GA, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2021.1890026

Reference49 articles.

1. Invasive Candidiasis

2. Multistate Point-Prevalence Survey of Health Care–Associated Infections

3. Invasive candidiasis

4. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

5. Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of the fernane-type triterpenoids as anti-fungal drugs;Frontiers in Pharmacology;2024-08-21

2. Management of invasive candidiasis: A focus on rezafungin, ibrexafungerp, and fosmanogepix;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-05-09

3. Synthesis and evaluation of the antifungal activity of 5-hydroxy-3-phenyl-1H-pyrazole-1-carbothioamide for use in the oral environment;Journal of Oral Biology and Craniofacial Research;2024-03

4. Candida auris, a singular emergent pathogenic yeast: its resistance and new therapeutic alternatives;European Journal of Clinical Microbiology & Infectious Diseases;2022-10-06

5. Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective;Clinical Infectious Diseases;2022-01-05